Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2002 Oct 15;367(Pt 2):475–481. doi: 10.1042/BJ20020677

Evidence that the dephosphorylation of Ser(535) in the epsilon-subunit of eukaryotic initiation factor (eIF) 2B is insufficient for the activation of eIF2B by insulin.

Xuemin Wang 1, Maarten Janmaat 1, Anne Beugnet 1, Fiona E M Paulin 1, Christopher G Proud 1
PMCID: PMC1222905  PMID: 12133000

Abstract

Eukaryotic initiation factor (eIF) 2B is a guanine-nucleotide exchange factor that plays a key role in the regulation of protein synthesis. It is activated by insulin, serum and other agents that stimulate general protein synthesis. The largest (epsilon) subunit of eIF2B is a substrate for glycogen synthase kinase (GSK)-3 in vitro, and phosphorylation by GSK3 inhibits the activity of eIF2B. The site of phosphorylation has previously been identified as Ser(535). GSK3 is inactivated by phosphorylation in response to insulin or serum. In Chinese-hamster ovary cells, insulin and serum bring about the dephosphorylation of Ser(535) in vivo, concomitantly with the phosphorylation of GSK3, and these effects are mediated through signalling via phosphoinositide 3-kinase. We have made use of inhibitors of GSK3 to determine whether GSK3 is responsible for phosphorylation of Ser(535) in vivo and to explore the role of phosphorylation of Ser(535) in the regulation of eIF2B. Treatment of cells with LiCl or with either of two recently developed GSK3 inhibitors, SB-415286 and SB-216763, brought about the dephosphorylation of Ser(535), which strongly indicates that this site is indeed a target for GSK3 in vivo. However, these compounds did not elicit significant activation of eIF2B, indicating, consistent with conclusions from one of our previous studies, that additional inputs are required for the activation of eIF2B. Our results also show that each of the inhibitors used affects overall protein synthesis and have additional effects on translation factors or signalling pathways apparently unrelated to their effects on GSK3, indicating that caution must be exercised when interpreting data obtained using these compounds.

Full Text

The Full Text of this article is available as a PDF (237.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avruch J., Belham C., Weng Q., Hara K., Yonezawa K. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog Mol Subcell Biol. 2001;26:115–154. doi: 10.1007/978-3-642-56688-2_5. [DOI] [PubMed] [Google Scholar]
  2. Berlanga J. J., Santoyo J., De Haro C. Characterization of a mammalian homolog of the GCN2 eukaryotic initiation factor 2alpha kinase. Eur J Biochem. 1999 Oct;265(2):754–762. doi: 10.1046/j.1432-1327.1999.00780.x. [DOI] [PubMed] [Google Scholar]
  3. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  4. Campbell L. E., Wang X., Proud C. G. Nutrients differentially regulate multiple translation factors and their control by insulin. Biochem J. 1999 Dec 1;344(Pt 2):433–441. [PMC free article] [PubMed] [Google Scholar]
  5. Coghlan M. P., Culbert A. A., Cross D. A., Corcoran S. L., Yates J. W., Pearce N. J., Rausch O. L., Murphy G. J., Carter P. S., Roxbee Cox L. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem Biol. 2000 Oct;7(10):793–803. doi: 10.1016/s1074-5521(00)00025-9. [DOI] [PubMed] [Google Scholar]
  6. Cohen P., Alessi D. R., Cross D. A. PDK1, one of the missing links in insulin signal transduction? FEBS Lett. 1997 Jun 23;410(1):3–10. doi: 10.1016/s0014-5793(97)00490-0. [DOI] [PubMed] [Google Scholar]
  7. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., Hemmings B. A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 1995 Dec 21;378(6559):785–789. doi: 10.1038/378785a0. [DOI] [PubMed] [Google Scholar]
  8. Dennis P. B., Fumagalli S., Thomas G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev. 1999 Feb;9(1):49–54. doi: 10.1016/s0959-437x(99)80007-0. [DOI] [PubMed] [Google Scholar]
  9. Dickens M., Chin J. E., Roth R. A., Ellis L., Denton R. M., Tavaré J. M. Characterization of insulin-stimulated protein serine/threonine kinases in CHO cells expressing human insulin receptors with point and deletion mutations. Biochem J. 1992 Oct 1;287(Pt 1):201–209. doi: 10.1042/bj2870201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Eldar-Finkelman H., Seger R., Vandenheede J. R., Krebs E. G. Inactivation of glycogen synthase kinase-3 by epidermal growth factor is mediated by mitogen-activated protein kinase/p90 ribosomal protein S6 kinase signaling pathway in NIH/3T3 cells. J Biol Chem. 1995 Jan 20;270(3):987–990. doi: 10.1074/jbc.270.3.987. [DOI] [PubMed] [Google Scholar]
  11. Fabian J. R., Kimball S. R., Heinzinger N. K., Jefferson L. S. Subunit assembly and guanine nucleotide exchange activity of eukaryotic initiation factor-2B expressed in Sf9 cells. J Biol Chem. 1997 May 9;272(19):12359–12365. doi: 10.1074/jbc.272.19.12359. [DOI] [PubMed] [Google Scholar]
  12. Favata M. F., Horiuchi K. Y., Manos E. J., Daulerio A. J., Stradley D. A., Feeser W. S., Van Dyk D. E., Pitts W. J., Earl R. A., Hobbs F. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 1998 Jul 17;273(29):18623–18632. doi: 10.1074/jbc.273.29.18623. [DOI] [PubMed] [Google Scholar]
  13. Garrett S., Menold M. M., Broach J. R. The Saccharomyces cerevisiae YAK1 gene encodes a protein kinase that is induced by arrest early in the cell cycle. Mol Cell Biol. 1991 Aug;11(8):4045–4052. doi: 10.1128/mcb.11.8.4045. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gilligan M., Welsh G. I., Flynn A., Bujalska I., Diggle T. A., Denton R. M., Proud C. G., Docherty K. Glucose stimulates the activity of the guanine nucleotide-exchange factor eIF-2B in isolated rat islets of Langerhans. J Biol Chem. 1996 Jan 26;271(4):2121–2125. doi: 10.1074/jbc.271.4.2121. [DOI] [PubMed] [Google Scholar]
  15. Gingras A. C., Raught B., Sonenberg N. Control of translation by the target of rapamycin proteins. Prog Mol Subcell Biol. 2001;27:143–174. doi: 10.1007/978-3-662-09889-9_6. [DOI] [PubMed] [Google Scholar]
  16. Gingras A. C., Raught B., Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu Rev Biochem. 1999;68:913–963. doi: 10.1146/annurev.biochem.68.1.913. [DOI] [PubMed] [Google Scholar]
  17. Gomez E., Pavitt G. D. Identification of domains and residues within the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2Bepsilon) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation. Mol Cell Biol. 2000 Jun;20(11):3965–3976. doi: 10.1128/mcb.20.11.3965-3976.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Kimball S. R., Horetsky R. L., Jefferson L. S. Implication of eIF2B rather than eIF4E in the regulation of global protein synthesis by amino acids in L6 myoblasts. J Biol Chem. 1998 Nov 20;273(47):30945–30953. doi: 10.1074/jbc.273.47.30945. [DOI] [PubMed] [Google Scholar]
  19. Kimball S. R., Jefferson L. S. Effect of diabetes on guanine nucleotide exchange factor activity in skeletal muscle and heart. Biochem Biophys Res Commun. 1988 Oct 31;156(2):706–711. doi: 10.1016/s0006-291x(88)80900-8. [DOI] [PubMed] [Google Scholar]
  20. Kleijn M., Proud C. G. The activation of eukaryotic initiation factor (eIF)2B by growth factors in PC12 cells requires MEK/ERK signalling. FEBS Lett. 2000 Jul 7;476(3):262–265. doi: 10.1016/s0014-5793(00)01743-9. [DOI] [PubMed] [Google Scholar]
  21. Kleijn M., Welsh G. I., Scheper G. C., Voorma H. O., Proud C. G., Thomas A. A. Nerve and epidermal growth factor induce protein synthesis and eIF2B activation in PC12 cells. J Biol Chem. 1998 Mar 6;273(10):5536–5541. doi: 10.1074/jbc.273.10.5536. [DOI] [PubMed] [Google Scholar]
  22. Klein P. S., Melton D. A. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci U S A. 1996 Aug 6;93(16):8455–8459. doi: 10.1073/pnas.93.16.8455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Litchfield D. W., Dobrowolska G., Krebs E. G. Regulation of casein kinase II by growth factors: a reevaluation. Cell Mol Biol Res. 1994;40(5-6):373–381. [PubMed] [Google Scholar]
  24. Lucas F. R., Goold R. G., Gordon-Weeks P. R., Salinas P. C. Inhibition of GSK-3beta leading to the loss of phosphorylated MAP-1B is an early event in axonal remodelling induced by WNT-7a or lithium. J Cell Sci. 1998 May;111(Pt 10):1351–1361. doi: 10.1242/jcs.111.10.1351. [DOI] [PubMed] [Google Scholar]
  25. Pavitt G. D., Ramaiah K. V., Kimball S. R., Hinnebusch A. G. eIF2 independently binds two distinct eIF2B subcomplexes that catalyze and regulate guanine-nucleotide exchange. Genes Dev. 1998 Feb 15;12(4):514–526. doi: 10.1101/gad.12.4.514. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Proud C. G. Regulation of eukaryotic initiation factor eIF2B. Prog Mol Subcell Biol. 2001;26:95–114. doi: 10.1007/978-3-642-56688-2_4. [DOI] [PubMed] [Google Scholar]
  27. Quevedo C., Alcázar A., Salinas M. Two different signal transduction pathways are implicated in the regulation of initiation factor 2B activity in insulin-like growth factor-1-stimulated neuronal cells. J Biol Chem. 2000 Jun 23;275(25):19192–19197. doi: 10.1074/jbc.M000238200. [DOI] [PubMed] [Google Scholar]
  28. Rowlands A. G., Panniers R., Henshaw E. C. The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. J Biol Chem. 1988 Apr 25;263(12):5526–5533. [PubMed] [Google Scholar]
  29. Scheuner D., Song B., McEwen E., Liu C., Laybutt R., Gillespie P., Saunders T., Bonner-Weir S., Kaufman R. J. Translational control is required for the unfolded protein response and in vivo glucose homeostasis. Mol Cell. 2001 Jun;7(6):1165–1176. doi: 10.1016/s1097-2765(01)00265-9. [DOI] [PubMed] [Google Scholar]
  30. Sood R., Porter A. C., Ma K., Quilliam L. A., Wek R. C. Pancreatic eukaryotic initiation factor-2alpha kinase (PEK) homologues in humans, Drosophila melanogaster and Caenorhabditis elegans that mediate translational control in response to endoplasmic reticulum stress. Biochem J. 2000 Mar 1;346(Pt 2):281–293. [PMC free article] [PubMed] [Google Scholar]
  31. Souza G. M., Lu S., Kuspa A. YakA, a protein kinase required for the transition from growth to development in Dictyostelium. Development. 1998 Jun;125(12):2291–2302. doi: 10.1242/dev.125.12.2291. [DOI] [PubMed] [Google Scholar]
  32. Stambolic V., Ruel L., Woodgett J. R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Curr Biol. 1996 Dec 1;6(12):1664–1668. doi: 10.1016/s0960-9822(02)70790-2. [DOI] [PubMed] [Google Scholar]
  33. Summers S. A., Kao A. W., Kohn A. D., Backus G. S., Roth R. A., Pessin J. E., Birnbaum M. J. The role of glycogen synthase kinase 3beta in insulin-stimulated glucose metabolism. J Biol Chem. 1999 Jun 18;274(25):17934–17940. doi: 10.1074/jbc.274.25.17934. [DOI] [PubMed] [Google Scholar]
  34. Sutherland C., Cohen P. The alpha-isoform of glycogen synthase kinase-3 from rabbit skeletal muscle is inactivated by p70 S6 kinase or MAP kinase-activated protein kinase-1 in vitro. FEBS Lett. 1994 Jan 24;338(1):37–42. doi: 10.1016/0014-5793(94)80112-6. [DOI] [PubMed] [Google Scholar]
  35. Sutherland C., Leighton I. A., Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J. 1993 Nov 15;296(Pt 1):15–19. doi: 10.1042/bj2960015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Thevelein J. M., de Winde J. H. Novel sensing mechanisms and targets for the cAMP-protein kinase A pathway in the yeast Saccharomyces cerevisiae. Mol Microbiol. 1999 Sep;33(5):904–918. doi: 10.1046/j.1365-2958.1999.01538.x. [DOI] [PubMed] [Google Scholar]
  37. Wang X., Campbell L. E., Miller C. M., Proud C. G. Amino acid availability regulates p70 S6 kinase and multiple translation factors. Biochem J. 1998 Aug 15;334(Pt 1):261–267. doi: 10.1042/bj3340261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Wang X., Li W., Williams M., Terada N., Alessi D. R., Proud C. G. Regulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase. EMBO J. 2001 Aug 15;20(16):4370–4379. doi: 10.1093/emboj/20.16.4370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wang X., Paulin F. E., Campbell L. E., Gomez E., O'Brien K., Morrice N., Proud C. G. Eukaryotic initiation factor 2B: identification of multiple phosphorylation sites in the epsilon-subunit and their functions in vivo. EMBO J. 2001 Aug 15;20(16):4349–4359. doi: 10.1093/emboj/20.16.4349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Welsh G. I., Foulstone E. J., Young S. W., Tavaré J. M., Proud C. G. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase. Biochem J. 1994 Oct 1;303(Pt 1):15–20. doi: 10.1042/bj3030015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Welsh G. I., Miller C. M., Loughlin A. J., Price N. T., Proud C. G. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 1998 Jan 9;421(2):125–130. doi: 10.1016/s0014-5793(97)01548-2. [DOI] [PubMed] [Google Scholar]
  42. Welsh G. I., Miyamoto S., Price N. T., Safer B., Proud C. G. T-cell activation leads to rapid stimulation of translation initiation factor eIF2B and inactivation of glycogen synthase kinase-3. J Biol Chem. 1996 May 10;271(19):11410–11413. doi: 10.1074/jbc.271.19.11410. [DOI] [PubMed] [Google Scholar]
  43. Welsh G. I., Proud C. G. Glycogen synthase kinase-3 is rapidly inactivated in response to insulin and phosphorylates eukaryotic initiation factor eIF-2B. Biochem J. 1993 Sep 15;294(Pt 3):625–629. doi: 10.1042/bj2940625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Welsh G. I., Proud C. G. Regulation of protein synthesis in Swiss 3T3 fibroblasts. Rapid activation of the guanine-nucleotide-exchange factor by insulin and growth factors. Biochem J. 1992 May 15;284(Pt 1):19–23. doi: 10.1042/bj2840019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Welsh G. I., Stokes C. M., Wang X., Sakaue H., Ogawa W., Kasuga M., Proud C. G. Activation of translation initiation factor eIF2B by insulin requires phosphatidyl inositol 3-kinase. FEBS Lett. 1997 Jun 30;410(2-3):418–422. doi: 10.1016/s0014-5793(97)00579-6. [DOI] [PubMed] [Google Scholar]
  46. Williams D. D., Pavitt G. D., Proud C. G. Characterization of the initiation factor eIF2B and its regulation in Drosophila melanogaster. J Biol Chem. 2000 Nov 1;276(6):3733–3742. doi: 10.1074/jbc.M008041200. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES